Healthy volunteers help scientists see how new drug ENX-104 works in the brain
NCT ID NCT07253272
First seen Jan 07, 2026 · Last updated May 23, 2026 · Updated 16 times
Summary
This early-stage study tested a single dose of the experimental drug ENX-104 in 10 healthy volunteers. Researchers used PET scans to see how much of the drug attached to certain brain receptors and checked for side effects. The goal was to gather safety and dosing information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Parexel London EPCU
London, Middlesex, HA1 3UJ, United Kingdom
Conditions
Explore the condition pages connected to this study.